NANOBIOTIX SA NANOBIOTIX ORD SH (0QAV.L) Financials
0QAV.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2021-12-31 | ? | ? |
2021-09-30 | ? | ? |
2021-06-30 | 123.9 million | 82.5 million |
2021-03-31 | ? | ? |
0QAV.L Free Cash Flow and Stock based compensation
No data available :(
0QAV.L Net Income
No data available :(
0QAV.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2021-12-31 | - | - | - |
2021-09-30 | - | - | - |
2021-06-30 | 102.3 million | - | - |
2021-03-31 | - | - | - |
0QAV.L Shares Outstanding
0QAV.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2021-12-31 | 91500 | - | - | - |
2021-09-30 | 91500 | - | - | - |
2021-06-30 | 22500 | - | 10.0 million | - |
2021-03-31 | 22500 | - | - | - |
0QAV.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2021-12-31 | - | - |
2021-09-30 | - | - |
2021-06-30 | 10000 | - |
2021-03-31 | - | - |
0QAV.L
Price: €6.74
52 week price:
Earnings Per Share: -1.36 EUR
P/E Ratio: -5.14
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 1.5 million